Adult liver transplantation at UCL: update 2002.

IF 1.5 4区医学 Q2 Medicine

Acta Gastro-Enterologica Belgica Pub Date : 2004-04-01

J Lerut, J Matthys, J Lemaire, V Van Thuyne, O Ciccarelli, P Goffette, A Peeters, S Aunac, M Boddeus, M A Carlier, E Danse, M De Kock, Ch De Reyck, M Donataccio, A Geubel, D Gonze, P Goubau, D Latinne, P F Laterre, A Luts, G Cool, J B Otte, Y Horsmans, J Martinez, G Orlando, J Rahier, R Reding, M Reynaert, P Starkel, Ch Sempoux, St Talpe, L Van Obbergh, F Veyckemans, P Wallemacq, X Wittebolle, F Roggen

引用次数: 0

Abstract

The authors present the results of a single centre study of 587 liver transplants performed in 522 adults during the period 1984-2002. Results have improved significantly over time due to better pre-, peri- and post-transplant care. One, five, ten and fifteen year actuarial survivals for the whole patient group are 81.2; 69.8; 58.9 and 51.2%. The high incidence of de novo tumors (12.3%), of cardiovascular diseases (7.5%) and of end-stage renal function (3.6%) should be further incentives to tailor the immunosuppression to the individual patient and to direct the attention of the transplant physician to the long-term quality of life of the liver recipient.

本刊更多论文

伦敦大学学院成人肝移植:2002年更新。

作者介绍了1984-2002年间522名成人进行的587例肝移植单中心研究的结果。随着时间的推移，由于更好的移植前、移植期和移植后护理，结果显著改善。整个患者组的1年、5年、10年和15年精算生存率为81.2;69.8;58.9%和51.2%。新发肿瘤(12.3%)、心血管疾病(7.5%)和终末期肾功能(3.6%)的高发生率应进一步促使免疫抑制针对个体患者，并将移植医生的注意力引向肝脏受体的长期生活质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Gastro-Enterologica Belgica 医学-胃肠肝病学

CiteScore

2.80

自引率

20.00%

发文量

审稿时长

>12 weeks

期刊介绍： The Journal Acta Gastro-Enterologica Belgica principally publishes peer-reviewed original manuscripts, reviews, letters to editors, book reviews and guidelines in the field of clinical Gastroenterology and Hepatology, including digestive oncology, digestive pathology, as well as nutrition. Pure animal or in vitro work will not be considered for publication in the Journal. Translational research papers (including sections of animal or in vitro work) are considered by the Journal if they have a clear relationship to or relevance for clinical hepato-gastroenterology (screening, disease mechanisms and/or new therapies). Case reports and clinical images will be accepted if they represent an important contribution to the description, the pathogenesis or the treatment of a specific gastroenterology or liver problem. The language of the Journal is English. Papers from any country will be considered for publication. Manuscripts submitted to the Journal should not have been published previously (in English or any other language), nor should they be under consideration for publication elsewhere. Unsolicited papers are peer-reviewed before it is decided whether they should be accepted, rejected, or returned for revision. Manuscripts that do not meet the presentation criteria (as indicated below) will be returned to the authors. Papers that go too far beyond the scope of the journal will be also returned to the authors by the editorial board generally within 2 weeks. The Journal reserves the right to edit the language of papers accepted for publication for clarity and correctness, and to make formal changes to ensure compliance with AGEB’s style. Authors have the opportunity to review such changes in the proofs.